Viatris (MEX:MYL) E10: MXN-0.53 (As of Mar. 2026)


MEX:MYL Viatris Inc MEX:MYL
46 GF Score
Price MXN282.19
GF Value MXN190.26
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Viatris E10?

Viatris MEX:MYL 46 E10 is MXN-0.53 as of Mar. 2026. GuruFocus rates MEX:MYL with a GF Score™ of 46/100 and a GF Value™ of MXN190.26 (Significantly Overvalued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Viatris's adjusted earnings per share data for the three months ended in Mar. 2026 was MXN2.705. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN-0.53 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Viatris's average E10 Growth Rate was -115.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Viatris was 42.40% per year. The lowest was -34.10% per year. And the median was 11.55% per year.

As of today (2026-06-28), Viatris's current stock price is MXN282.19. Viatris's E10 for the quarter that ended in Mar. 2026 was MXN-0.53. Viatris's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Viatris was 308.00. The lowest was 8.87. And the median was 15.50.


Viatris  (MEX:MYL) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Viatris was 308.00. The lowest was 8.87. And the median was 15.50.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Viatris E10 Related Terms


Viatris E10 Historical Data

* Premium members only.

The historical data trend for Viatris's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viatris E10 Chart

Viatris Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.17 18.49 12.43 10.02 -0.71

Viatris Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.06 0.00 0.72 -0.71 -0.53

MEX:MYL vs NBIX, UTHR, ELAN: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Viatris's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Viatris Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Viatris's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Viatris's Shiller PE Ratio falls into.


MEX:MYL
46GF Score
Viatris Inc MEX:MYL
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viatris E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Viatris's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=2.705/330.2130*330.2130
=2.705

Current CPI (Mar. 2026) = 330.2130.

Viatris Quarterly Data

per share eps CPI Adj_EPS
201606 6.103 241.018 8.362
201609 -4.447 241.428 -6.082
201612 16.081 241.432 21.994
201703 2.259 243.801 3.060
201706 9.942 244.955 13.402
201709 2.904 246.819 3.885
201712 9.034 246.524 12.101
201803 3.088 249.554 4.086
201806 1.375 251.989 1.802
201809 6.360 252.439 8.319
201812 1.963 251.233 2.580
201903 -0.970 254.202 -1.260
201906 -6.339 256.143 -8.172
201909 7.305 256.759 9.395
201912 0.754 256.974 0.969
202003 0.938 258.115 1.200
202006 1.847 257.797 2.366
202009 7.953 260.280 10.090
202012 -31.628 260.474 -40.096
202103 -17.579 264.877 -21.915
202106 -4.578 271.696 -5.564
202109 5.346 274.310 6.435
202112 -4.513 278.802 -5.345
202203 6.571 287.504 7.547
202206 5.231 296.311 5.829
202209 5.833 296.808 6.489
202212 16.182 296.797 18.004
202303 3.425 301.836 3.747
202306 3.772 305.109 4.082
202309 4.703 307.789 5.046
202312 -10.864 306.746 -11.695
202403 1.494 312.332 1.580
202406 -4.946 314.175 -5.198
202409 1.575 315.301 1.649
202412 -8.968 315.605 -9.383
202503 -52.168 319.799 -53.867
202506 0.000 322.561 0.000
202509 -2.018 324.800 -2.052
202512 -5.402 324.054 -5.505
202603 2.705 330.213 2.705

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of MXN-0.53 mean?
Viatris (MEX:MYL) has a E10 of MXN-0.53 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Viatris and its competitors.
Is Viatris' E10 too high?
Viatris' current E10 is MXN-0.53. Overall, Viatris has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Viatris' E10 compare to NBIX and UTHR?
Viatris' E10 of MXN-0.53 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Viatris and its competitors. Viatris's current E10 is MXN-0.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viatris stock overvalued right now?
Based on GuruFocus' analysis, Viatris (MEX:MYL) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN190.26, compared to a current price of MXN282.19 — trading 48.3% above its estimated fair value. The current E10 is MXN-0.53. Viatris' overall GF Score™ is 46/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Viatris (MEX:MYL), the current E10 is MXN-0.53 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Viatris (MEX:MYL) Overvalued in 2026?

Based on GuruFocus' analysis, Viatris stock appears to be overvalued. The current stock price of MXN282.19 is trading 48.3% above its estimated GF Value™ of MXN190.26. GuruFocus considers Viatris to be Significantly Overvalued.

Key valuation signals for MEX:MYL:

  • E10: MXN-0.53
  • GF Value™: MXN190.26 vs. price of MXN282.19 (48.3% above fair value)
  • GF Score™: 46/100 with 8 warning signs

No single metric tells the full story. See the MEX:MYL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Viatris Business Description

Address 1000 Mylan Boulevard, Canonsburg, PA, USA, 15317
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
46GF Score

Get the complete analysis for MEX:MYL

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN282.19
Price
MXN190.26
GF Value